Safety evaluation of endometrial biopsy aiming to analyze ERA/EMMA/ALICE for patient with repeated IVF failure, recurrent pregnancy losses and chronic endometritis.
- Conditions
- Safety evaluation of endometrial biopsy aiming to analyze ERA/EMMA/ALICE for patient with repeated IVF failure, recurrent pregnancy losses and chronic endometritis.
- Registration Number
- JPRN-UMIN000049894
- Lead Sponsor
- Tohoku university
- Brief Summary
We recruited and completed 10 subjects as scheduled. Main out come measured was presence of absence of adverse events. We did not observe any adverse event. Secondary endpoints was percentage of defective specimens which incompatible for analysis. There was no defective specimen and we could obtain result from all specimens from all 10 participants.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 10
Not provided
(1)Patient who dose not fulfill inclusion criteria (2)Patient who dose not agree with study participation (3)Patient who are receiving treatment for endometrial hyperplasia or endometrial cancer (4)Patient who have difficulty for endometrial biopsy due to congenital mullerian duct anomaly, Bleeding tendency and/or who requires hospital admission for anesthesia. (5)Patient who are pregnant or suspicious of pregnancy (6)Patient who have psychosomatic problem and have been decided to difficult to participant.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of complication related to endometrial biopsy for ERA/EMMA/ALICE.
- Secondary Outcome Measures
Name Time Method Assessment of ERA/EMMA/ALICE test suitability of biopsied endometrial samples